🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a study to assess the safety, tolerability, and immunogenicity of V...
Status
Completed
Location
Multiple Locations
Start Date
2011-04-19
Trial ID
NCT01337167
Treatments Being Tested
Primary objective: This study aimed to demonstrate the non-inferiority of ...
Status
Completed
Location
Investigational Site Number : 2031006
Start Date
2018-12-14
Trial ID
NCT03547271
This study forms part of an integrated, multi-study effort to identify pote...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-10
Trial ID
NCT04515368
Treatments Being Tested
Primary objectives: * To assess the safety profile of each SP0202 formulat...
Status
Completed
Location
The Children's Clinic Of Jonesboro PA Site Number : 8400143
Start Date
2020-05-22
Trial ID
NCT04398706
Treatments Being Tested
The purpose of this study is to assess duration of protection for GSK DTaP ...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02447978
This two-stage study evaluates the immunogenicity, safety, and tolerability...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT00289913
Treatments Being Tested
The purpose of this study was to evaluate the optimal vaccination schedule ...
Status
Completed
Location
Multiple Locations
Start Date
2009-12-16
Trial ID
NCT01049035
Treatments Being Tested
The purpose of this study is to assess if there is any immune interference ...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-09-14
Trial ID
NCT03207750
Treatments Being Tested
This is a Phase Ⅲ, open-label, single arm design combined with randomized, ...
Status
Recruiting
Location
Hanoi Medical University
Start Date
2026-08-20
Trial ID
NCT07793227
The purpose of the study is to provide data on the safety and immunogenicit...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT00355654
Treatments Being Tested